SCHEMBL9877140

SCHEMBL9877140

Cc1ccc(SCCNC(=N)NCCCc2c[nH]cn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
HPGD P15428 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 6/20 0.39
MAPT P10636 6/20 0.39
ALOX12 P18054 5/20 0.39
KMT2A Q03164 5/20 0.39
HTT P42858 4/20 0.39
MEN1 O00255 4/20 0.39
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
PKM P14618 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.37
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867195 0.95 HPGD (0.39) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL9866021 0.89 TEAD1 (0.43) ALDH1A1MAPK1LMNAMAPTALOX12
SCHEMBL9865147 0.88 MTNR1A (0.41) ALDH1A1HPGDLMNAKMT2AHTT
SCHEMBL9866034 0.85 ALDH1A1 (0.45) ALDH1A1HPGDLMNAMAPTALOX12
SCHEMBL9866274 0.84 TEAD1 (0.38) ALDH1A1LMNAMAPTKMT2AHTT
SCHEMBL9867497 0.84 KMT2A (0.38) ALDH1A1HPGDKMT2AMEN1NPC1
SCHEMBL9771031 0.81 DRD2 (0.36) KMT2APKMDRD2DRD4
SCHEMBL9877143 0.81 HPGD (0.37) ALDH1A1HPGDLMNAMAPTALOX12
SCHEMBL9867202 0.80 HRH4 (0.37) ALDH1A1HPGDKMT2AKDM4EPKM
SCHEMBL9865982 0.80 NPC1 (0.44) ALDH1A1HPGDCYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed